{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:51:11Z","timestamp":1789865471914,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1997,12,1]],"date-time":"1997-12-01T00:00:00Z","timestamp":880934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1997,12,1]],"date-time":"1997-12-01T00:00:00Z","timestamp":880934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biometals"],"published-print":{"date-parts":[[1997,12]]},"DOI":"10.1023\/a:1018312113969","type":"journal-article","created":{"date-parts":[[2003,2,6]],"date-time":"2003-02-06T22:08:17Z","timestamp":1044569297000},"page":"247-256","source":"Crossref","is-referenced-by-count":19,"title":["Liver iron depletion and toxicity of the iron chelator Deferiprone (L, CP20) in the guinea pig"],"prefix":"10.1007","volume":"10","author":[{"given":"A.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Alder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Maserei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Berdoukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kontoghiorghes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"170396_CR1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1182\/blood.V80.3.593.593","volume":"80","author":"FN Al-Refaie","year":"1992","unstructured":"Al-Refaie FN, Wonke B, Hoffbrand AV, et al. 1992 Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major. Blood\n80, 593\u2013599.","journal-title":"Blood"},{"key":"170396_CR2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2141.1995.tb05274.x","volume":"91","author":"FN Al-Refaie","year":"1995","unstructured":"Al-Refaie FN, Hershko C, Hoffbrand AV, et al. 1995 Results of long-term deferiprone (L1) therapy: a report by the International Study Group on oral iron chelators. Br J Haematol\n91, 224\u2013229.","journal-title":"Br J Haematol"},{"key":"170396_CR3","first-page":"49","volume-title":"Thalassemia: Pathophysiology and Management","author":"E. Baker","year":"1988","unstructured":"Baker E. 1988 Biological screens for iron chelators. In:Thalassemia: Pathophysiology and Management. New York Alan R. Liss Inc. March of Dimes Birth Defects Foundation, Original Article Series;23(5b): 49\u201362."},{"key":"170396_CR4","volume-title":"Evaluation of new iron chelators in the hepatocyte in culture","author":"E Baker","year":"1987","unstructured":"Baker E, Richardson DR, Gross S, et al. 1987 Evaluation of new iron chelators in the hepatocyte in culture. Eighth International Conference on Proteins of Iron Transport and Storage, 143 Montreal, P. Ponkan, McGill University."},{"key":"170396_CR5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2141.1990.tb07888.x","volume":"76","author":"AN Bartlett","year":"1990","unstructured":"Bartlett AN, Hoffbrand AV, Kontoghiorghes GJ. 1990 Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) II: Clinical observations. Brit J Hematol\n76, 301\u2013304.","journal-title":"Brit J Hematol"},{"key":"170396_CR6","first-page":"298","volume":"29","author":"J Ben Nun","year":"1988","unstructured":"Ben Nun J, Alder VA, Cringle SJ, Constable, IJC. 1988 A new method for oxygen supply to acute ischemic retina. Invest Ophthalmol & Vis Sci\n29, 298\u2013304.","journal-title":"Invest Ophthalmol & Vis Sci"},{"key":"170396_CR7","first-page":"345","volume":"56","author":"DR Blake","year":"1985","unstructured":"Blake DR, Winyard P, Lunec J, et al. 1985 Cerebral and ocular toxicity induced by desferrioxamine. Quart J Med\n56, 345\u2013355.","journal-title":"Quart J Med"},{"key":"170396_CR8","volume-title":"Iron Metabolism in Man","author":"TH Bothwell","year":"1979","unstructured":"Bothwell TH, Charlton RW, Cook JD, Finch CA. 1979. Iron Metabolism in Man. Oxford: Blackwell Scientific Publications."},{"key":"170396_CR9","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1042\/bj2630989","volume":"263","author":"BE Chan","year":"1989","unstructured":"Chan BE, Roeser HP, Nikles AC. 1989 Cytosolic ferritin and lipid-associated ferritin are metabolically different in guinea-pig livers. Biochem J\n263, 989\u2013992.","journal-title":"Biochem J"},{"key":"170396_CR10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/bj2670535","volume":"267","author":"BE Chan","year":"1990","unstructured":"Chan BE, Roeser HP, Nikles C. 1990 Ascorbin acid deficiency affects the metabolism of cytosolic ferritin but not lipid-associated ferritin in livers of guinea pigs. Biochem J\n267, 535\u2013537.","journal-title":"Biochem J"},{"key":"170396_CR11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-3476(88)80375-5","volume":"113","author":"S de Virgillis","year":"1988","unstructured":"de Virgillis S, Congia M, Frau F, et al. 1988 Deferoxamineinduced growth retardation in patients with thalassemia major. J Pediatr\n113, 661\u2013669.","journal-title":"J Pediatr"},{"key":"170396_CR12","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/0140-6736(93)92444-X","volume":"341","author":"C Hershko","year":"1993","unstructured":"Hershko C. 1993 Development of oral iron chelator L1. Lancet\n341, 1088\u20131089.","journal-title":"Lancet"},{"key":"170396_CR13","first-page":"391","volume-title":"Iron Metabolism in Health and Disease","author":"C. Hershko","year":"1994","unstructured":"Hershko C. 1994 Iron chelators. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron Metabolism in Health and Disease. 391\u2013426 London, W.B. Saunders Co. Ltd. ketohydroxypyridine iron chelators intended for clinical use:in vivostudies in rabbits. Br J Hematol\n62, 607-613."},{"key":"170396_CR14","doi-asserted-by":"crossref","first-page":"L11","DOI":"10.1016\/S0020-1693(00)85549-8","volume":"136","author":"GJ Kontoghiorghes","year":"1987","unstructured":"Kontoghiorghes GJ, Sheppard L. 1987 Simple synthesis of the potent iron chelators 1-alkyl-3-hydroxy-2-methylpyrid-4-ones. Inorganica Chimica Acta\n136, L11\u2013L12.","journal-title":"Inorganica Chimica Acta"},{"key":"170396_CR15","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/bmj.295.6612.1509","volume":"295","author":"GH Kontoghiorghes","year":"1987","unstructured":"Kontoghiorghes GH, Aldouri MA, Hoffbrand AV, et al. 1987 Effective chelation of iron in beta-thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1). Br Med J Clin Res\n295, 1509\u20131512.","journal-title":"Br Med J Clin Res"},{"key":"170396_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2141.1990.tb07887.x","volume":"76","author":"GJ Kontoghiorghes","year":"1990","unstructured":"Kontoghiorghes GJ, Bartlett AN, Hoffbrand AV, et al. 1990 Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1): Iron chelation and metabolic studies. Brit J Hematol\n76, 295\u2013300.","journal-title":"Brit J Hematol"},{"key":"170396_CR17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ajh.2830420403","volume":"42","author":"GJ Kontoghiorghes","year":"1993","unstructured":"Kontoghiorghes GJ, Barr J, Nortey P, Sheppard L. 1993a Selection of a new generation of orally active a-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload. Am J Hematol\n42, 340\u2013349.","journal-title":"Am J Hematol"},{"key":"170396_CR18","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/0140-6736(93)90925-7","volume":"341","author":"GJ Kontoghiorghes","year":"1993","unstructured":"Kontoghiorghes GJ, Agarwal MB, Kersten MJ, et al. 1993b Future of oral iron chelator deferiprone (L1). Lancet\n341, 1479\u20131480.","journal-title":"Lancet"},{"key":"170396_CR19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2141.1971.tb07024.x","volume":"20","author":"DA Lipschitz","year":"1991","unstructured":"Lipschitz DA, Bothwell TH, Seftel HC, et al. 1991 The role of ascorbic acid in the metabolism of storage iron. Br J Hematol\n20, 155\u2013163.","journal-title":"Br J Hematol"},{"key":"170396_CR20","volume-title":"The Clinical Approach to Thalassemia","author":"B Modell","year":"1984","unstructured":"Modell B, Berdoukas V. 1984The Clinical Approach to Thalassemia. New York: Grune & Stratton, Inc."},{"key":"170396_CR21","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0140-6736(90)92962-H","volume":"336","author":"NF Olivieri","year":"1990","unstructured":"Olivieri NF, Koren G, Hermann C, et al. 1990a Comparison of oral iron chelator-L1 and desferrioxamine in iron-loaded patients. Lancet\n336, 1275\u20131279.","journal-title":"Lancet"},{"key":"170396_CR22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1749-6632.1990.tb24324.x","volume":"612","author":"NF Olivieri","year":"1990","unstructured":"Olivieri NF, Templeton DM, Koren G, et al. 1990b Evaluation of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients. Ann NY Acad Sci USA\n612, 369\u2013377.","journal-title":"Ann NY Acad Sci USA"},{"key":"170396_CR23","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood.V79.10.2741.bloodjournal79102741","volume":"79","author":"NF Olivieri","year":"1992","unstructured":"Olivieri NF, Koren G, Matsui D, et al. 1992 Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia-intermedia. Blood\n79, 2741\u20132748.","journal-title":"Blood"},{"key":"170396_CR24","first-page":"555","volume":"57","author":"CH Park","year":"1987","unstructured":"Park CH, Bacon BR, Brittenham EM, Tavill AS. 1987 Pathology of dietary carbonyl iron overload in rats. Lab Invest\n57, 555\u2013563.","journal-title":"Lab Invest"},{"key":"170396_CR25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1600-0609.1986.tb02282.x","volume":"36","author":"MJ Pippard","year":"1986","unstructured":"Pippard MJ, Jackson MJ, Hoffman K, et al. 1986 Iron chelation using subcutaneous infusions of diethylene triamine penta-acetic acid (DTPA). Scand J Hematol\n36, 466\u2013472. differing metabolism of the iron chelating site. Br J Hematol\n85, 159-168.","journal-title":"Scand J Hematol"},{"key":"170396_CR26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0378-5955(91)90004-S","volume":"51","author":"D Robertson","year":"1991","unstructured":"Robertson D, Wilson SA. 1991 Changes in cochlear sensitivity do not alter relative thresholds of different spontaneous rate categories of primary auditory nerve fibres. Hearing Res\n51, 29\u201332.","journal-title":"Hearing Res"},{"key":"170396_CR27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0090-9556(25)08575-7","volume":"20","author":"S Singh","year":"1992","unstructured":"Singh S, Epemolu RO, Dobbin PS, et al. 1992 Urinary metabolic profiles in human and rat of 1,2-dimethyl-substituted and 1,2-diethyl-substituted 3-hydroxypyridin-4-ones. Drug Metabolism and Disposition\n20, 256\u2013261.","journal-title":"Drug Metabolism and Disposition"},{"key":"170396_CR28","first-page":"9","volume":"33","author":"JD Torrance","year":"1968","unstructured":"Torrance JD, Bothwell TH. 1968 A simple technique for measuring storage iron concentrations in formalised liver samples. S Afr J Med Sci\n33, 9\u201311.","journal-title":"S Afr J Med Sci"},{"key":"170396_CR29","doi-asserted-by":"crossref","unstructured":"Ward C, Saltman P, Ripley L, et al. 1977 Correlation of serum ferritin and liver ferritin iron in the anemic, normal and iron-loaded rat. Am J Clin Nutr\n30","DOI":"10.1093\/ajcn\/30.7.1054"}],"container-title":["Biometals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018312113969.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1018312113969\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018312113969.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T17:11:43Z","timestamp":1749575503000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1018312113969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["170396"],"URL":"https:\/\/doi.org\/10.1023\/a:1018312113969","relation":{},"ISSN":["0966-0844","1572-8773"],"issn-type":[{"value":"0966-0844","type":"print"},{"value":"1572-8773","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,12]]}}}